New Jersey Senate Bill 4222: Improves access to lower-cost generic and biosimilar drugs.

New Jersey · 222 session

Status: In committee

Latest action

Introduced in the Senate, Referred to Senate Commerce Committee (2026-05-14)

See how S 4222 affects you on CapitolKey

Browse more bills · CapitolKey home